» Articles » PMID: 20422064

Piperacillin-associated Pulmonary Infiltrates with Eosinophilia: a Case Report

Overview
Journal Can Respir J
Publisher Wiley
Specialty Pulmonary Medicine
Date 2010 Apr 28
PMID 20422064
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

A case of pulmonary infiltrates with eosinophilia attributed to piperacillin tazobactam therapy is described. A 54-year-old woman was treated for a suspected severe urinary tract infection with piperacillin tazobactam. Four days later, she developed fever, chills, shortness of breath and intermittent chest pains. Eosinophilia was noted in peripheral blood and, subsequently, on bronchoalveolar lavage. Transbronchial biopsy showed tissue infiltrates with eosinophilia. No evidence of bacterial, fungal and parasitic infection, or vasculitis was observed. Her symptoms and peripheral eosinophilia subsided after drug discontinuation and oral prednisone treatment. Piperacillin is an extended-spectrum penicillin antibiotic prescribed for moderate to severe infections. The common adverse reactions to piperacillin include nausea, vomiting, diarrhea and rash. Pulmonary infiltrates with eosinophilia is a rare adverse reaction, but one that may result in significant morbidity. Physicians should be aware of this rare but important adverse reaction to piperacillin.

Citing Articles

Undetected Causes of Death in Hospitalized Elderly with COVID-19: Lessons from Autopsy.

Malezieux-Picard A, Ferrer Soler C, De Macedo Ferreira D, Gaud-Luethi E, Serratrice C, Mendes A J Clin Med. 2021; 10(7).

PMID: 33804890 PMC: 8037274. DOI: 10.3390/jcm10071337.


A combination of predispositions and exposures as responsible for acute eosinophilic pneumonia.

Amiconi S, Hirl B Multidiscip Respir Med. 2014; 9(1):7.

PMID: 24475879 PMC: 3909902. DOI: 10.1186/2049-6958-9-7.


Chronic eosinophilic pneumonia due to radiographic contrast administration: an orphan disease?.

Hohenforst-Schmidt W, Riedel A, Zarogoulidis P, Franke C, Gschwendtner A, Huang H Drug Des Devel Ther. 2012; 6:385-9.

PMID: 23251088 PMC: 3523559. DOI: 10.2147/DDDT.S37937.

References
1.
Schelhorn J, Hofer L, Syrbe G, Polzer U . [Drug-induced eosinophilic pneumonia]. Nervenarzt. 2008; 79(6):696-8. DOI: 10.1007/s00115-008-2437-y. View

2.
Allen J . Drug-induced eosinophilic lung disease. Clin Chest Med. 2004; 25(1):77-88. DOI: 10.1016/S0272-5231(03)00141-2. View

3.
Jeong Y, Kim K, Seo I, Lee C, Lee K, Kim K . Eosinophilic lung diseases: a clinical, radiologic, and pathologic overview. Radiographics. 2007; 27(3):617-37. DOI: 10.1148/rg.273065051. View

4.
Solomon J, Schwarz M . Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia. Semin Respir Crit Care Med. 2006; 27(2):192-7. DOI: 10.1055/s-2006-939522. View

5.
LIEBOW A, CARRINGTON C . The eosinophilic pneumonias. Medicine (Baltimore). 1969; 48(4):251-85. DOI: 10.1097/00005792-196907000-00001. View